KT&G (033780) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
24 Jun, 2026Executive summary
Q2 2024 consolidated revenue rose 6.6% YoY to KRW 1.438 trillion, with operating profit up 30.6% YoY to KRW 321.5 billion, and net income up 57.5% to KRW 318 billion, driven by strong tobacco and global business performance.
EPS increased 59.5% YoY to KRW 2,754.
The company is executing a three-year shareholder return plan (2024–2026) with KRW 1.8 trillion in dividends and KRW 1 trillion in share buybacks, including a new interim dividend and additional buyback/cancellation in H2 2024.
A new corporate value enhancement plan will be disclosed in H2 2024.
H1 2024 revenue was ₩2,716.0 billion (-0.6% YoY), with operating profit at ₩558.6 billion and net profit at ₩598.4 billion.
Financial highlights
EBITDA rose 25.4% YoY to KRW 383.1 billion, with a margin of 26.9%.
Operating profit margin improved to 29.8% YoY; net income margin at 22.3%.
Cash and cash equivalents at quarter-end were KRW 1,024.2 billion.
EPS for H1 2024 was ₩5,206.
Total assets: ₩13,545.6 billion; total equity: ₩9,489.1 billion.
Outlook and guidance
2024 consolidated revenue growth revised to 2.5%-3% YoY (from 10%-10.5%), and operating profit now expected to remain flat YoY.
Tobacco business expected to maintain robust growth and meet prior guidance in H2 2024; segment guidance: revenue +9.0–9.5%, operating profit +6.0–6.5% YoY.
HFF revenue projected to decline 2.5%-3% YoY, with operating profit down 28%-28.5% YoY.
Real Estate revenue expected to drop 34.5%-35% YoY, with operating profit down 92.5%-93% YoY.
Guidance for stable dividend and ongoing share buybacks through 2026.
Latest events from KT&G
- Record FY24 results with global growth, higher dividends, and aggressive buybacks.033780
Q4 202424 Jun 2026 - Record tobacco growth and shareholder returns offset declines in net income and real estate.033780
Q3 202424 Jun 2026 - Q1 2025 revenue up 15.4% YoY, strong profit growth, and ongoing share buybacks.033780
Q1 202524 Jun 2026 - Record revenue and operating profit growth, but net income fell; dividends and buybacks increased.033780
Q2 202524 Jun 2026 - Record revenue and profit, net income up 73.4%, guidance raised, global expansion planned.033780
Q3 202524 Jun 2026 - Record Q1 revenue and profit growth driven by global tobacco and health foods, with stronger dividends ahead.033780
Q1 202622 Jun 2026 - 2025 saw record revenue, profit, and shareholder returns, led by global CC and real estate growth.033780
Q4 20255 Feb 2026 - Accelerated global growth, record shareholder returns, and new Altria partnership drive expansion.033780
Investor Day 2025 Presentation23 Sep 2025